Deborah Turner Kochevar is Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). They have made 15 open-market trades across 2 companies since 2009, most recently 2026-05-21.
CIK 0001448579
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $28K since 2019, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRL | SELL | 2021-08-06 | 2021-08-10 | $406.43 | $2.9M | +3.1% | +7.5% | -9.2% |
| CRL | SELL | 2020-08-07 | 2020-08-11 | $216.24 | $1.0M | +2.3% | +1.6% | +12.2% |
| ELAN | BUY | 2019-09-11 | 2019-09-12 | $27.95 | $28K | -3.2% | -6.4% | -5.8% |
| CRL | SELL | 2018-09-04 | 2018-09-05 | $123.66 | $504K | +4.0% | +4.5% | +7.6% |
| CRL | SELL | 2017-05-12 | 2017-05-16 | $87.97 | $52K | +3.5% | +6.3% | +9.7% |
| CRL | SELL | 2017-05-12 | 2017-05-16 | $87.93 | $693K | +3.5% | +6.3% | +9.7% |
| CRL | SELL | 2017-05-12 | 2017-05-16 | $88.03 | $26K | +3.5% | +6.3% | +9.7% |
| CRL | SELL | 2015-08-03 | 2015-08-05 | $76.69 | $479K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2015-03-02 | 2015-03-03 | $76.59 | $168K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-05-22 | 2014-05-23 | $53.15 | $322K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2014-05-22 | 2014-05-23 | $53.30 | $165K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2013-08-02 | 2013-08-06 | $45.92 | $465K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2013-08-02 | 2013-08-06 | $46.02 | $205K | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2011-05-09 | 2011-05-10 | $40.60 | $1.2M | -6.2% | -1.2% | -1.2% |
| CRL | SELL | 2009-08-11 | 2009-08-12 | $32.50 | $62K | -6.2% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.